通过MAOA抑制来重新编程前列腺癌的免疫冷景观
Anil K Singh1, Boyang Jason Wu2
1Pharmaceutical Sciences, Washington State University, Spokane, Washington, USA.
Journal for immunotherapy of cancer
|September 10, 2025
概括
向 stromal monoamine oxidase A (MAOA) 可以重新编程前列腺癌瘤的免疫微环境 (TIME). 无活化MAOA增强CD8+T细胞活性,并与免疫疗法协同,以减少瘤生长.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 前列腺癌 (PC) 通常具有"免疫学冷"的瘤免疫微环境 (TIME),限制了免疫治疗的有效性.
- 斯特罗姆单胺氧化酶A (MAOA) 是一种降解神经递质的酶,影响神经内分泌系统和免疫反应.
- 了解结构因素对于克服PC的免疫逃避至关重要.
研究的目的:
- 研究 stromal MAOA 在调节PC瘤免疫微环境 (TIME) 中的作用.
- 探索MAOA作为增强PC免疫疗法的潜在治疗标.
- 分析WNT5A-Ca2+-NFATC1信号通路在MAOA介导免疫调节中的参与.
主要方法:
- 在癌症相关纤维细胞中对MAOA水平的遗传和药理学操纵.
- 分析CD8+T细胞介导的细胞毒性.
- 调查WNT5A-Ca2+-NFATC1信号轴的情况.
- 在临床前模型中评估MAOA无活化与免疫检查点阻塞疗法的协同作用.
主要成果:
- 改变癌症相关纤维细胞中MAOA水平重新编程了PC TIME.
- MAOA调节通过WNT5A-Ca2+-NFATC1通路影响了CD8+T细胞的细胞毒性.
- MAOA 失活与免疫检查点阻塞协同作用,抑制前列腺瘤生长.
结论:
- 斯特罗曼MAOA是前列腺癌免疫反应的关键调节者.
- 向MAOA提供了一种新的策略,以提高PC的免疫疗法疗效.
- 马奥是一种有前途的组合疗法目标,可以逆转前列腺瘤的进展.
相关概念视频
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K


